The serum concentrations of ionized calcium (iCa), corrected automatically for serum pH, were measured in 67 cases with breast cancer (16 positive cases and 51 negative cases for bone metastasis). The serum concentration of iCa in the cases of positive bone metastasis was significantly higher than that in the negative cases (p<0.005). As osteoclastic bone metastasis occurred frequently in breast cancer, the measurements of serum concentrations of iCa might be of help as a supplementary marker of the diagnosis of bone metastasis
BACKGROUND: One of the greatest problems in treating advanced prostate carcinoma is monitoring t...
BACKGROUND: One of the greatest problems in treating advanced prostate carcinoma is monitoring t...
Hypercalcemia is relatively frequent in malignancy with or without osteolytic bone metastases. It is...
A characteristic feature of many cancer types is their ability to metastasise to the skeleton. Bone ...
Summary: After the introduction (1, 2) and methodical evaluation (3, 4) of a new method for the quan...
A characteristic feature of many cancer types is their ability to metastasise to the skeleton. Bone ...
A panel of bone turn-over markers was assessed in 75 normocalcemic patients bearing bone metastases ...
For the diagnosis of bone metastasis in breast cancer patients during systemic treatment serum tumor...
ritin, and tissue polypeptide antigen (determined by the M3 monocolonal antibody, TPS) were measured...
The development of bone metastases in cancer can be monitored easily using three markers: 24 h urina...
The development of bone metastases in cancer can be monitored easily using three markers: 24 h urina...
Serum bone alkaline phosphatase (BALP), serum carboxy-terminal propeptide of type I procollagen (PIC...
The development of bone metastases in cancer can be monitored easily using three markers: 24 h urina...
BACKGROUND: One of the greatest problems in treating advanced prostate carcinoma is monitoring t...
Experimental, epidemiological and clinical studies suggest that calcium and/or its regulating hormon...
BACKGROUND: One of the greatest problems in treating advanced prostate carcinoma is monitoring t...
BACKGROUND: One of the greatest problems in treating advanced prostate carcinoma is monitoring t...
Hypercalcemia is relatively frequent in malignancy with or without osteolytic bone metastases. It is...
A characteristic feature of many cancer types is their ability to metastasise to the skeleton. Bone ...
Summary: After the introduction (1, 2) and methodical evaluation (3, 4) of a new method for the quan...
A characteristic feature of many cancer types is their ability to metastasise to the skeleton. Bone ...
A panel of bone turn-over markers was assessed in 75 normocalcemic patients bearing bone metastases ...
For the diagnosis of bone metastasis in breast cancer patients during systemic treatment serum tumor...
ritin, and tissue polypeptide antigen (determined by the M3 monocolonal antibody, TPS) were measured...
The development of bone metastases in cancer can be monitored easily using three markers: 24 h urina...
The development of bone metastases in cancer can be monitored easily using three markers: 24 h urina...
Serum bone alkaline phosphatase (BALP), serum carboxy-terminal propeptide of type I procollagen (PIC...
The development of bone metastases in cancer can be monitored easily using three markers: 24 h urina...
BACKGROUND: One of the greatest problems in treating advanced prostate carcinoma is monitoring t...
Experimental, epidemiological and clinical studies suggest that calcium and/or its regulating hormon...
BACKGROUND: One of the greatest problems in treating advanced prostate carcinoma is monitoring t...
BACKGROUND: One of the greatest problems in treating advanced prostate carcinoma is monitoring t...
Hypercalcemia is relatively frequent in malignancy with or without osteolytic bone metastases. It is...